CD274 and cancer: Since the N-linked glycosylation of PD-L1 and PD-1 has been shown to be essential for their ability to mediate immune evasion, scientists have rationally developed multiple small-molecule drugs that target N-glycosylation for use as cancer treatment and evaluated them in several tumor models (Table 1).